A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis

36

A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis

Tags:

Previous Article

The Wnt–NAD+ axis in cancer, aging, and tissue regeneration

Proteomics and AI detects early signs of ALS in plasma years before symptoms appear

Related Posts

Bridging the gaps between JCV infection models and human disease

Bridging the gaps between JCV infection models and huma...

94

Regional brain volume changes in Hakim’s disease versus Alzheimer’s and mild cognitive impairment

Regional brain volume changes in Hakim’s disease versus...

430

Opposing regulation of the STING pathway in hepatic stellate cells by NBR1 and p62 determines the progression of hepatocellular carcinoma

Opposing regulation of the STING pathway in hepatic ste...

49